Navigation Links
International conference on Ayurveda to be held on Kerala

On the global ayurveda submit to be held on Friday about 100 delegates are proposed to participate from all parts of the world like Russia, Italy, Brazil, Britain and south Korea//.

Scientist and research scholars of all leading Indian university and academic institutions will participate in the three-day submit of global ayurveda meet.

On the eve of the birth century celebration of Vaidyaratnam Group of institutions founder Ashtavaidyan Padamsri E.T. Neelakandhan Mooss, Ayurveda submit is conducted on Dec 9.

In a press release E.T. Neelakandhan Mooss (Junior) informed that nearly 1000 delegates from 30 ayurveda colleges will participate in the Ayurveda summit 2005.

Lifestyles causing disease, ayurveda utilizing biotechnology & therapy using rasayana are the sessions briefed in the summit.

Press release also informed that doctors belonging to non-ayurvedic medicine field would also make presentations to enhance disciplinary approach internally.

Stalls containing books on ayurveda will be kept for display by leading ayurveda medicine manufacturers on Ayurveda submit.
'"/>




Page: 1

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International Teleradiology: The Future Of Radiologic Diagnosis
9. John Mendelsohn M.D, chosen for an International Award
10. Thailand To Procure Botulism Antitoxin Internationally
11. International Rating System To Be Introduced For Hospitals In India
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: International conference Ayurveda held Kerala

(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood ... at UC Irvine and the Salk Institute have opened ... prevent stroke-induced brain damage. , A complex and devastating ... and primary reason for disability in the U.S. The ... lets blood-borne material into the brain, causing the permanent ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... ... ... -- R. Shane Jackson, president of LocumTenens.com and executive vice president of Jackson ... member meeting of 2010, which took place on March 25 in Atlanta, Ga. The ...
... longer when they aren,t standing, study finds , WEDNESDAY, April ... new research suggests that patients would be happier if their ... And for doctors, taking a seat doesn,t necessarily have to ... when doctors sat down during a hospital visit, patients ...
... too short or too tall, things are looking up, or ... in The FASEB Journal ( http://www.fasebj.org ) explains ... offers insight into what goes wrong with growth disorders and ... these insights into the mechanisms controlling body growth will help ...
... breath and bested standard test, study found , WEDNESDAY, ... system dubbed the "electronic nose," Italian researchers were able ... diagnostic tools. , The electronic nose detected nearly 90 ... percent who were accurately diagnosed in the traditional way ...
... ... Tahitian Noni Bioactive Beverages , ... Provo, UT (Vocus) April 7, 2010 -- Tahitian Noni International (TNI) announced that ... company has responded. Tahitian Noni International believes that no other product in the industry will ...
... SilverStone ... and 10 at the Peabody Orlando in Orlando, Florida. In addition to hosting a ... also sponsoring the breakout session entitled "Managing Employee Injuries: Caring for Your Employees While ... ...
Cached Medicine News:Health News:R. Shane Jackson Selected as Panelist for Center for Health Transformation Member Meeting 2Health News:R. Shane Jackson Selected as Panelist for Center for Health Transformation Member Meeting 3Health News:Sitting Docs Have Happier Patients 2Health News:Sitting Docs Have Happier Patients 3Health News:Scientists find out why living things are the size they are -- and none other 2Health News:'Electronic Nose' Sniffs Out Asthma 2Health News:'Electronic Nose' Sniffs Out Asthma 3Health News:Not All Fruits Are Superfruits: Not One Network Marketing Superfruit Company Has Accepted Tahitian Noni's Challenge 2Health News:SilverStone Group to Attend Comfort Keepers Annual Conference in Orlando 2
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Combination Clinical Trials ... SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... the company,s lead drug candidate, voreloxin (formerly,SNS-595), including updated results ... single agent in relapsed or refractory patients with acute,myeloid leukemia ...
... Requip XL Improved Symptoms in Patients Not Optimally ... "Off" Time by Nearly Two Hours Per Day, ... (NYSE: GSK ) today announced the approval ... for the treatment,of the signs and symptoms of ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 2U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 3U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 4U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 5
Speculum with malleable plate to support flap during ablation of thestromal bed....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Available with shaft straight or angled 45 degrees....
Open blade design with aspiration capabilities for removing fluids from the operative site....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Medicine Products: